Saturday, November 2, 2024
HomeTagsAutoimmune disease

autoimmune disease

Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score, Thyroid Eye Disease

Horizon Therapeutics plc announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics